Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 540

1.

IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.

Mattia E, Ruffatti A, Tonello M, Meneghel L, Robecchi B, Pittoni M, Gallo N, Salvan E, Teghil V, Punzi L, Plebani M.

Clin Chem Lab Med. 2014 Sep;52(9):1329-33. doi: 10.1515/cclm-2014-0039.

PMID:
24651022
2.

Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.

Meneghel L, Ruffatti A, Gavasso S, Tonello M, Mattia E, Spiezia L, Tormene D, Hoxha A, Fedrigo M, Simioni P.

Clin Chim Acta. 2015 Jun 15;446:201-5. doi: 10.1016/j.cca.2015.04.033. Epub 2015 Apr 30.

PMID:
25935129
3.

The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.

Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.

J Rheumatol. 2001 Dec;28(12):2637-43.

PMID:
11764209
4.

Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.

Li R, Daguzan M, Vandermijnsbrugge F, Gyling M, Cantinieaux B.

Acta Clin Belg. 2014 Dec;69(6):433-8. doi: 10.1179/2295333714Y.0000000060. Epub 2014 Aug 7.

PMID:
25103595
5.

A contribution to detection of anticardiolipin and anti-β2glycoprotein I antibodies: Comparison between a home-made ELISA and a fluorescence enzyme immunoassay.

Mattia E, Ruffatti A, Meneghel L, Tonello M, Faggian D, Hoxha A, Fedrigo M, Punzi L, Plebani M.

Clin Chim Acta. 2015 Jun 15;446:93-6. doi: 10.1016/j.cca.2015.04.012. Epub 2015 Apr 17.

PMID:
25892672
6.

Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity.

Carmo-Pereira S, Bertolaccini ML, Escudero-Contreras A, Khamashta MA, Hughes GR.

Ann Rheum Dis. 2003 Jun;62(6):540-3.

7.

Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.

Iwaniec T, Kaczor MP, Celińska-Löwenhoff M, Polański S, Musiał J.

Thromb Res. 2017 May;153:90-94. doi: 10.1016/j.thromres.2017.02.019. Epub 2017 Feb 24.

PMID:
28363116
8.

Novel enzyme immunoassay system for simultaneous detection of six subclasses of antiphospholipid antibodies for differential diagnosis of antiphospholipid syndrome.

Nojima J, Motoki Y, Hara K, Sakata T, Ichihara K.

Blood Coagul Fibrinolysis. 2017 Jun;28(4):316-322. doi: 10.1097/MBC.0000000000000599.

PMID:
27676644
9.

The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method.

Meneghel L, Ruffatti A, Gavasso S, Tonello M, Mattia E, Spiezia L, Campello E, Hoxha A, Fedrigo M, Punzi L, Simioni P.

Clin Chem Lab Med. 2015 Jun;53(7):1083-9. doi: 10.1515/cclm-2014-0925.

PMID:
25720075
10.

[Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome].

Fujieda Y, Shida H, Oku K, Bohgaki T, Amengual O, Horita T, Yasuda S, Atsumi T.

Nihon Rinsho Meneki Gakkai Kaishi. 2014;37(5):430-6. doi: 10.2177/jsci.37.430. Japanese.

11.
12.

Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies.

Ofer-Shiber S, Molad Y.

Blood Coagul Fibrinolysis. 2015 Apr;26(3):261-6. doi: 10.1097/MBC.0000000000000218.

PMID:
25526601
13.

APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.

Suh-Lailam BB, Cromar A, Davis KW, Tebo AE.

Int J Clin Exp Pathol. 2012;5(3):210-5. Epub 2012 Mar 25.

14.

Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.

Pericleous C, Ferreira I, Borghi O, Pregnolato F, McDonnell T, Garza-Garcia A, Driscoll P, Pierangeli S, Isenberg D, Ioannou Y, Giles I, Meroni PL, Rahman A.

PLoS One. 2016 Jun 2;11(6):e0156407. doi: 10.1371/journal.pone.0156407. eCollection 2016.

15.

Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.

Forastiero R.

Lupus. 2014 Oct;23(12):1252-4. doi: 10.1177/0961203314531635.

PMID:
25228718
16.

Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.

Hoxha A, Ruffatti A, Mattia E, Meneghel L, Tonello M, Salvan E, Pengo V, Punzi L.

Clin Chem Lab Med. 2015 Jul;53(8):1265-70. doi: 10.1515/cclm-2014-1129.

PMID:
25562605
17.

Anticardiolipin and anti-beta2glycoprotein-I antibodies in patients with systemic lupus erythematosus: comparison between Colombians and Spaniards.

Cucurull E, Espinoza LR, Mendez E, Molina JF, Molina J, Ordi-Ros J, Gharavi AE.

Lupus. 1999;8(2):134-41.

PMID:
10192508
18.

IgA anticardiolipin and anti-beta2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus.

Cucurull E, Gharavi AE, Diri E, Mendez E, Kapoor D, Espinoza LR.

Am J Med Sci. 1999 Jul;318(1):55-60.

PMID:
10408762
19.

Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.

Inanç M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S, Isenberg DA.

Br J Rheumatol. 1998 Oct;37(10):1089-94.

PMID:
9825748
20.

Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.

Stojanovich L, Kontic M, Djokovic A, Marisavljevic D, Ilijevski N, Stanisavljevic N, Mikovic Z, Petkovic M, Kovcin V.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2):234-42. Epub 2013 Jan 7.

PMID:
23306109

Supplemental Content

Support Center